Health and Nutrition

Discovery of in vivo Chemical Probes (R01)

This Funding Opportunity Announcement (FOA) intends to support investigators who have interest and capability to join efforts for the discovery of in vivo chemical probes. It is expected that applicants will have in hand the starting compounds (validated hits) for chemical optimization and bioassays for testing new analog compounds.

Change of Grantee Organization (Type 7 Parent)

The National Institutes of Health (NIH) hereby notify grantee organizations holding specific types of NIH grants, listed in the full Funding Opportunity Announcement (FOA), that applications for change of grantee organization may be submitted in response to this FOA. This assumes such a change is programmatically permitted for the particular grant.

Innovative Therapies and Tools for Screenable Disorders in Newborns (R01)

This Funding Opportunity Announcement (FOA) encourages Research Project Grant (R01) applications from institutions/ organizations that propose research relevant to the basic understanding and development of therapeutic interventions for currently screened conditions and high priority genetic conditions for which screening could be possible in the near future.In this FOA, a high priority condition is one for which the development of an efficacious therapy would make the condition amenable to newborn screening.

Ethical, Legal, and Social Implications (ELSI) of Genomic Research Small Research Grant Program (R03)

This Funding Opportunity Announcement (FOA) invites Small Research Grant (R03) applications that propose to study the ethical, legal and social implications (ELSI) of human genome research.Applications should propose small, self-contained research projects, such as those that involve single investigators.Of particular interest are projects that propose normative or conceptual analyses, including focused legal, economic, philosophical, anthropological, or historical analyses of new or emerging issues.

Ethical, Legal, and Social Implications (ELSI) of Genomic Research Exploratory/Developmental Research Program (R21)

This Funding Opportunity Announcement (FOA) invites Exploratory/Developmental Research Program Grant (R21) applications that propose to study the ethical, legal and social implications (ELSI) of human genome research.Applications should propose exploratory or developmental studies that break new ground or extend previous discoveries in new directions.Of particular interest are studies that explore the implications of new or emerging genomic technologies or novel uses of genomic information.

Research on Autism Spectrum Disorders (R21)

The purpose of this Funding Opportunity Announcement (FOA) is to encourage research grant applications to support research designed to elucidate the etiology, epidemiology, diagnosis, treatment, and optimal means of service delivery in relation to Autism Spectrum Disorders (ASD).

Lab to Marketplace: Tools for Brain and Behavioral Research (R43/R44)

The NIH and other research sponsors invest a significant amount of funds in the development of new technologies to study the brain and behavior, from basic and clinical perspectives, through a variety of mechanisms, including, from NIH, the R01, R21, R33, P01, P41, and P50 grants. This investment has produced a large number of technologies that include hardware (e.g., instruments, devices, etc.), software (e.g., computational models, informatics tools, data analytic methods, etc.) and wetware (e.g., cell-free assays, bioactive agents, imaging probes, etc.).

Research on Chronic Overlapping Pain Conditions (R01)

The purpose of this Funding Opportunity Announcement (FOA) is to encourage epidemiological, clinical and translational research that will increase our understanding of the natural history, prevalence, biological mechanisms, psychological variables, and clinical risk factors responsible for the presence of multiple chronic pain conditions in people with pain. Recent clinical findings suggest that substantial overlap may exist between chronic pain conditions.

Research on Chronic Overlapping Pain Conditions (R21)

The purpose of this Funding Opportunity Announcement (FOA) is to encourage epidemiological, clinical and translational research that will increase our understanding of the natural history, prevalence, biological mechanisms, psychological variables, and clinical risk factors responsible for the presence of multiple chronic pain conditions in people with pain. Recent clinical findings suggest that substantial overlap may exist between chronic pain conditions.

Advancing Research in Voice Disorders (R01)

This funding opportunity announcement (FOA) seeks Research Project Grant (R01) applications that are focused on advancing our scientific knowledge of the Human Larynx and Human Voice Production in Health and Disease and optimal ways to prevent, evaluate, diagnose and clinically manage voice disorders.